Polycystic ovary syndrome: antimüllerian hormone and its role in the pathophysiology of the syndrome
Author:
- 26 August 2025
- journal article
- review article
- Published by Elsevier in Fertility and Sterility
- Vol. 124 (5) , 910-918
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Preventing and correcting polycystic ovary syndrome by targeting anti-Müllerian hormone signaling in minipuberty and adulthood in miceCell Metabolism, 2025
- Daughters of PCOS mothers and AMH plasma concentrations in pre-puberty and puberty: A meta-analysisEarly Human Development, 2025
- Models and Biomarkers for Ovarian Ageing2023
- Genetics of anti-Müllerian hormone and its signaling pathwayBest Practice & Research Clinical Endocrinology & Metabolism, 2022
- Antimullerian Hormone Levels and Association with Abortion and Preterm Delivery in Patients with Polycystic Ovary Syndrome Who Conceived with Assisted Reproductive TechniquesThe Journal of Obstetrics and Gynecology of India, 2022
- Polycystic ovary syndrome is transmitted via a transgenerational epigenetic processCell Metabolism, 2021
- New insights into anti-Müllerian hormone role in the hypothalamic–pituitary–gonadal axis and neuroendocrine developmentCellular and Molecular Life Sciences, 2020
- Welcome to the family: the anti-müllerian hormone receptorMolecular and Cellular Endocrinology, 1994
- Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cellsCell, 1986
- Pituitary gonadotropin responses to synthetic luteinizing hormone-releasing hormone in patients with typical and atypical polycystic ovary diseaseAmerican Journal of Obstetrics and Gynecology, 1975